Published 3 days ago • loading... • Updated 3 days ago

Fidaxomicin Use Remains Flat Despite Guideline Change for C difficile Treatment

Summary by contagionlive.com

At MAD-ID 2025, Dakota Rorie, PharmD, highlights cost and access barriers to uptake of preferred CDI therapy.

1 Articles

All

Left

Center

Right

At MAD-ID 2025, Dakota Rorie, PharmD, highlights cost and access barriers to uptake of preferred CDI therapy.

3 days ago

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Total News Sources1

Leaning Left0Leaning Right0Center0Last Updated2 days agoBias Distribution

No sources with tracked biases.

Untracked bias

Factuality

To view factuality data please Upgrade to Premium

To view ownership data please Upgrade to Vantage

contagionlive.com broke the news in 3 days ago on Friday, May 30, 2025.

Sources are mostly out of (0)